Recursion is seeking an Executive Director, Asset Strategy Leadership, to shape portfolio strategy across oncology and immunology assets. You will translate computational insights into strategic advantages and collaborate with clinical, BD, finance, and platform teams to optimize resource allocation.
The role blends science leadership with business acumen, driving asset differentiation, regulatory alignment, and patient impact at scale.
#J-18808-LjbffrExecutive Director, Asset Strategy (AI-Driven Biotech) in new york at Unknown Company
This position is listed as full time and onsite.